Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.166
-0.002 (-1.08%)
At close: Mar 6, 2026, 4:00 PM EST
0.172
+0.007 (3.93%)
After-hours: Mar 6, 2026, 7:59 PM EST
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
$43,333
Profits / Employee
-$2,995,667
Market Cap
8.74M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| Bolt Biotherapeutics | 40 |
| KALA BIO | 38 |
| Lunai Bioworks | 29 |
| NuCana | 22 |
| BiomX | 20 |
| SeaStar Medical Holding | 19 |
| Cardio Diagnostics Holdings | 15 |
ITRM News
- 21 days ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 4 months ago - Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
- 5 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
- 7 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire
- 7 months ago - Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Iterum Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire